Erkki Ruoslahti American medical researcher
Ruoslahti, Erkki.
Ruoslahti, Erkki, 1940-
VIAF ID: 71279835 ( Personal )
Permalink: http://viaf.org/viaf/71279835
Preferred Forms
-
100 0 _ ‡a Erkki Ruoslahti ‡c American medical researcher
-
-
100 1 _ ‡a Ruoslahti, Erkki
-
-
-
-
-
100 1 0 ‡a Ruoslahti, Erkki
-
100 1 _ ‡a Ruoslahti, Erkki
-
100 1 _ ‡a Ruoslahti, Erkki ‡d 1940-
-
100 1 _ ‡a Ruoslahti, Erkki ‡d 1940-
-
100 1 _ ‡a Ruoslahti, Erkki, ‡d 1940-
-
4xx's: Alternate Name Forms (8)
Works
Title | Sources |
---|---|
Chemistry of tumor-associated antigens |
![]() ![]() |
Extracellular matrix components, c1994: |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
Fibroblast surface protein |
![]() ![]() ![]() ![]() |
Gated Luminescence Imaging of Silicon Nanoparticles |
![]() |
Identification of a peptide recognizing cerebrovascular changes in mouse models of Alzheimer's disease. |
![]() |
Immunoadsorbents in protein purification |
![]() ![]() ![]() |
In silico molecular engineering for a targeted replacement in a tumor-homing peptide. |
![]() |
In vivo cation exchange in quantum dots for tumor-specific imaging |
![]() |
Integrin signaling and matrix assembly |
![]() |
iRGD peptide conjugation potentiates intraperitoneal tumor delivery of paclitaxel with polymersomes. |
![]() |
Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype. |
![]() |
Lymphangiogenesis and Cancer: Fig. 1 |
![]() |
Lymphatic zip codes in premalignant lesions and tumors |
![]() |
Magnetic luminescent porous silicon microparticles for localized delivery of molecular drug payloads |
![]() |
Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions. |
![]() |
Metastasis of tumor cells is enhanced by downregulation of Bit1. |
![]() |
Micellar hybrid nanoparticles for simultaneous magnetofluorescent imaging and drug delivery |
![]() |
Mitochondrial/cell-surface protein p32/gC1qR as a molecular target in tumor cells and tumor stroma. |
![]() |
Mitochondrial p32 protein is a critical regulator of tumor metabolism via maintenance of oxidative phosphorylation |
![]() |
Molecular changes in the vasculature of injured tissues |
![]() |
Molecular profiling of heart endothelial cells |
![]() |
The multicompartmental p32/gClqR as a new target for antibody-based tumor targeting strategies. |
![]() |
Nanoparticle amplification via photothermal unveiling of cryptic collagen binding sites |
![]() |
Nanoparticle-induced vascular blockade in human prostate cancer |
![]() |
Nanoparticles coated with the tumor-penetrating peptide iRGD reduce experimental breast cancer metastasis in the brain |
![]() |
Nanoparticles that communicate in vivo to amplify tumour targeting |
![]() |
Neuropilin-1 and heparan sulfate proteoglycans cooperate in cellular uptake of nanoparticles functionalized by cationic cell-penetrating peptides. |
![]() |
New Insights into "Permeability" as in the Enhanced Permeability and Retention Effect of Cancer Nanotherapeutics. |
![]() |
New p32/gC1qR Ligands for Targeted Tumor Drug Delivery |
![]() |
New way to activate caspases |
![]() |
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels |
![]() |
Peptide-directed highly selective targeting of pulmonary arterial hypertension |
![]() |
Peptide targeting of tumor lymph vessels. |
![]() |
Peptides selected for binding to clotted plasma accumulate in tumor stroma and wounds |
![]() |
Peptides targeting inflamed synovial vasculature attenuate autoimmune arthritis |
![]() |
Plasma fibronectin promotes lung metastasis by contributions to fibrin clots and tumor cell invasion |
![]() |
Porous Silicon Nanoparticle Delivery of Tandem Peptide Anti-Infectives for the Treatment of Pseudomonas aeruginosa Lung Infections. |
![]() |
Proapoptotic peptide-mediated cancer therapy targeted to cell surface p32. |
![]() |
Progressive vascular changes in a transgenic mouse model of squamous cell carcinoma |
![]() |
Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies |
![]() |
Protein kinase D is a positive regulator of Bit1 apoptotic function. |
![]() |
Proteolytic actuation of nanoparticle self-assembly. |
![]() |
Quantity and accessibility for specific targeting of receptors in tumours |
![]() |
R-Ras is a global regulator of vascular regeneration that suppresses intimal hyperplasia and tumor angiogenesis. |
![]() |
Recognition of dextran-superparamagnetic iron oxide nanoparticle conjugates (Feridex) via macrophage scavenger receptor charged domains. |
![]() |
Reprogramming human retinal pigmented epithelial cells to neurons using recombinant proteins. |
![]() |
The RGD story: a personal account. |
![]() |
Selection of phage-displayed peptides on live adherent cells in microfluidic channels |
![]() |
Selection strategies for anticancer antibody discovery: searching off the beaten path |
![]() |
Selective Targeting of a Novel Vasodilator to the Uterine Vasculature to Treat Impaired Uteroplacental Perfusion in Pregnancy. |
![]() |
Site-specific targeting of antibody activity in vivo mediated by disease-associated proteases. |
![]() |
Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels |
![]() |
Specialization of tumour vasculature |
![]() |
Specific penetration and accumulation of a homing peptide within atherosclerotic plaques of apolipoprotein E-deficient mice |
![]() |
Stage-specific vascular markers revealed by phage display in a mouse model of pancreatic islet tumorigenesis |
![]() |
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor β1 |
![]() |
Supramolecular nanoparticles that target phosphoinositide-3-kinase overcome insulin resistance and exert pronounced antitumor efficacy. |
![]() |
Synthesis of linear and cyclic peptide-PEG-lipids for stabilization and targeting of cationic liposome-DNA complexes. |
![]() |
Synthetic surfaces for human embryonic stem cell culture. |
![]() |
Systematic surface engineering of magnetic nanoworms for in vivo tumor targeting |
![]() |
Target-seeking antifibrotic compound enhances wound healing and suppresses scar formation in mice |
![]() |
Targeted Antiscarring Therapy for Tissue Injuries. |
![]() |
Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma |
![]() |
Targeted quantum dot conjugates for siRNA delivery. |
![]() |
Targeted silver nanoparticles for ratiometric cell phenotyping. |
![]() |
Targeted tumor-penetrating siRNA nanocomplexes for credentialing the ovarian cancer oncogene ID4 |
![]() |
Targeting atherosclerosis by using modular, multifunctional micelles. |
![]() |
Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display |
![]() |
Targeting of albumin-embedded paclitaxel nanoparticles to tumors |
![]() |
Targeting the prostate for destruction through a vascular address |
![]() |
Tissue-penetrating delivery of compounds and nanoparticles into tumors |
![]() |
TLE1 is an anoikis regulator and is downregulated by Bit1 in breast cancer cells |
![]() |
Trophoblast cell activation by trophinin ligation is implicated in human embryo implantation |
![]() |
Tumor-Penetrating Nanosystem Strongly Suppresses Breast Tumor Growth. |
![]() |
A tumor-penetrating peptide enhances circulation-independent targeting of peritoneal carcinomatosis |
![]() |
Tumor-Targeted Multimodal Optical Imaging with Versatile Cadmium-Free Quantum Dots |
![]() |
Urokinase-controlled tumor penetrating peptide. |
![]() |
Using shape effects to target antibody-coated nanoparticles to lung and brain endothelium. |
![]() |
Vascular changes in tumors resistant to a vascular disrupting nanoparticle treatment. |
![]() |
Vascular histomolecular analysis by sequential endoarterial biopsy in a shunt model of pulmonary hypertension |
![]() |